• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Professional Introduction to Compound with CAS No. 1261918-60-8 and Product Name: 4-(4-Benzyloxyphenyl)-2-cyanophenol

The compound with the CAS number 1261918-60-8 and the product name 4-(4-Benzyloxyphenyl)-2-cyanophenol represents a significant advancement in the field of pharmaceutical chemistry. This compound has garnered considerable attention due to its unique structural features and potential applications in medicinal chemistry. The presence of both a benzyloxy group and a cyano substituent in its molecular framework imparts distinct chemical properties that make it a promising candidate for further research and development.

Recent studies have highlighted the importance of aromatic compounds in drug design, particularly those incorporating heterocyclic structures. The 4-(4-Benzyloxyphenyl)-2-cyanophenol molecule, with its dual functionality, exhibits intriguing interactions with biological targets. The benzyloxy group is known to enhance solubility and metabolic stability, while the cyano group introduces a strong electron-withdrawing effect, which can modulate the reactivity and binding affinity of the compound. These features make it an attractive scaffold for developing novel therapeutic agents.

In the realm of medicinal chemistry, the synthesis and characterization of 4-(4-Benzyloxyphenyl)-2-cyanophenol have been subjects of extensive investigation. Advanced synthetic methodologies have been employed to optimize its production, ensuring high purity and yield. Techniques such as palladium-catalyzed cross-coupling reactions and nucleophilic substitution have been particularly effective in constructing the desired molecular architecture. These synthetic advancements underscore the compound's feasibility for large-scale production and subsequent pharmaceutical applications.

The pharmacological potential of 4-(4-Benzyloxyphenyl)-2-cyanophenol has been explored in various preclinical studies. Its structural motifs suggest interactions with enzymes and receptors involved in inflammatory pathways, making it a candidate for treating conditions such as arthritis and autoimmune disorders. Additionally, preliminary data indicate that this compound may exhibit antimicrobial properties, which could be valuable in addressing antibiotic-resistant infections. These findings align with the growing demand for multifunctional compounds that can target multiple disease pathways simultaneously.

One of the most compelling aspects of 4-(4-Benzyloxyphenyl)-2-cyanophenol is its versatility in drug design. The compound's dual functional groups allow for modifications at multiple sites, enabling chemists to fine-tune its pharmacokinetic and pharmacodynamic properties. This flexibility is crucial for developing personalized medicine approaches, where compounds are tailored to individual patient needs. Furthermore, the use of computational modeling techniques has facilitated a deeper understanding of how this molecule interacts with biological systems, providing insights into its potential therapeutic effects.

The regulatory landscape for pharmaceutical compounds like 4-(4-Benzyloxyphenyl)-2-cyanophenol is stringent but well-established. Compliance with Good Manufacturing Practices (GMP) ensures that the compound meets high-quality standards before being subjected to clinical trials. Regulatory agencies require thorough documentation of synthesis, purity, and stability data to support its safe use in humans. These rigorous standards reflect the importance of responsible drug development and highlight the commitment of researchers to delivering effective therapies.

Future directions for research on 4-(4-Benzyloxyphenyl)-2-cyanophenol include exploring its mechanism of action in greater detail. Understanding how this compound modulates biological pathways will provide critical insights into its therapeutic potential and help identify possible side effects. Additionally, investigating its interactions with other drug candidates could lead to synergistic effects that enhance treatment outcomes. Collaborative efforts between academic institutions and pharmaceutical companies are essential to accelerate these studies and bring this compound closer to clinical application.

The economic implications of developing novel compounds like 4-(4-Benzyloxyphenyl)-2-cyanophenol are significant. Pharmaceutical companies invest heavily in research and development, anticipating that successful candidates will generate substantial revenue once approved by regulatory agencies. However, the high costs associated with clinical trials and regulatory approvals necessitate robust scientific evidence to support their efficacy and safety. This underscores the importance of meticulous research design and execution in maximizing the chances of success.

In conclusion, 4-(4-Benzyloxyphenyl)-2-cyanophenol, with its CAS number 1261918-60-8, represents a promising advancement in pharmaceutical chemistry. Its unique structural features and potential therapeutic applications make it a valuable candidate for further research and development. As scientists continue to explore its pharmacological properties, this compound holds great promise for improving human health through innovative drug therapies.

• 548785-53-1(Benzonitrile, 2-methoxy-5-(methoxymethyl)- (9CI))
• 167832-66-8(2-(Benzyloxy)-6-methoxybenzonitrile)
• 838873-18-0(2,7-Naphthalenedicarbonitrile, 3-(phenylmethoxy)-)
• 503829-94-5(Benzonitrile, 4-[([1,1'-biphenyl]-4-yloxy)methyl]-)
• 117571-49-0(4-(4-Benzyloxyphenyl)benzonitrile)
• 94088-47-8(2,6-Dibenyloxy benzonitrile)
• 719274-37-0(Benzonitrile, 2-methoxy-4-(phenylmethoxy)-)
• 503829-92-3(Benzonitrile, 3-[([1,1'-biphenyl]-4-yloxy)methyl]-)
• 189439-24-5(4-(Benzyloxy)-2-hydroxybenzonitrile)
• 74511-44-7(2-(benzyloxy)benzonitrile)